Atipamezole

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtipamezole
Drug Alias NameMPV-1248
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsDepressive Disorder, MajorAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFinland
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorAnesthesia

Other Information

ATC CodeN/A
Related LinksN/A